Industry Advisory Council

Raphaël Rousseau, MD, PHD

Industry Advisory Council
Chief Medical Officer
Gritstone Oncology

Raphaël Rousseau is the Chief Medical Officer at Gritstone Oncology, responsible for leading the development of Gritstone’s cutting-edge neoantigen immunotherapy platform. Prior to this role he served as the Global Franchise Head of the Innovative Pediatric Drug Development (iPODD) group at Genentech, a member of the Roche Group. Prior to joining Roche in 2009, Raphaël was a professor of Medical and Pediatric Oncology at the University Claude Bernard in Lyon, France, where he established a clinical and translational research program in high-risk pediatric cancers. He also became a permanent expert for biomedical research within France’s Agency for the Safety of Medicinal Products. In 2008 he was awarded the Cancer Foundation Advanced Clinical Research Award in Sarcoma from the American Society of Clinical Oncology for his translational research project in pediatric osteosarcoma. Raphaël currently serves as Chair of the CureSearch Industry Advisory Council.

Pin It on Pinterest

Scroll to Top